Humacyte, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
HUMA Company Description
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.
HUMA Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view HUMA Smart Score
Score Breakdown
HUMA Company Description
Show More
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Show Less
$HUMA is featured in our Congress Buys and Congress Long-Short strategies.
See All StrategiesAll
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of HUMA by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by HUMA's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on HUMA's company Twitter account
WallStreetBets
Number of mentions of HUMA in WallStreetBets Daily Discussion
HUMA News
Recent insights relating to HUMA
CNBC Recommendations
Recent picks made for HUMA stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in HUMA
Corporate Flights
Flights by private jets registered to HUMA
Our Analysis